A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Kavingali Corp Announces Opening of Offices in Casper, Wyoming

Today Kavingali Corp. announced the opening of its new corporate headquarters in Casper Wyoming.

Currently, Kavingali Corp is introducing LOTUS FILMTM a hydrophobic self-cleaning applied thin film that is designed to be applied by spray or roller to glass and metal surfaces. The product was designed to assist in new levels of standards for commercial touch surfaces that offers an alternative to constant chemical cleaning.

Kavingali Corp has two versions of the film one designed for outdoor application that has been tested to remain effective for three to five years. The other interior version is designed to last over one year and can easily be applied to high traffic areas such as doors, elevators, escalators, and other high traffic areas in commercial settings. Both product versions are non- toxic but are not designed for use in food preparation or direct food contact applications. The company is currently researching how the Tungsten Trioxide in the LOTUS FILMTM (patent pending) might use natural light (blue light levels of visible light) and photocatalytic process to neutralize pathogens.

The company also has software and robotics divisions that are focused on efficient patient care and cost-effective treatment. ACRUSTM is a healthcare coding and utilization revenue system. It is designed to automate both the billing, quality of care, and utilization functions that are currently conducted by nursing staff manually. Designed to save typical hospital systems up to 45 percent of current departmental costs and provide significant realtime data to managers. The system employs machine learning software that can migrate and analyze both structured and unstructured (physician notes) and then apply algorithms and industry criteria both to code for billing and recommend placement status for billing. APIs are currently being designed to work with all EHR systems and commercial payer systems.

The company is focused on local hire and reutilizing displaced oilfield and gas workers to transition to high tech manufacturing to include custom robotic fingers, thin film coatings, and custom prototyping medical devices. Kavingali, Corp. has several products planned to be made locally and have the label “Made in Casper” and “Made in the USA”. In addition, the company also has patents pending for a 400-450 nm light device for the neutralization of pathogens (viruses) for escalator handrails and for physical therapy/occupational therapy collaborative robots.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

SABIC advises the project was initiated together with the dialysis department at Jessa Hospital, one of the largest non-university medical cluster in the Limburg region of Flanders, Belgium.
Dr. Sachita Shah, Sr. Director, Global Health, Butterfly Network, "Butterfly is proud to continue improving maternal health equity through Phase Two of the largest-scale handheld ultrasound distribution and training ever conducted in Sub-Saharan Africa. South Africa is an emerging market that continues to have disproportionately high rates of maternal mortality and stillbirth. Patients need easier access to antenatal imaging, and clinicians need better capabilities for screening high-risk conditions that lead to disproportionately worse pregnancy outcomes in rural areas in the public sector. Together with CHAI and GUSI, we can tackle this by making ultrasound much more accessible, so high-risk conditions can be identified earlier in care, which is known to improve outcomes.”
The clinical Study will enroll up to 97 patients at up to 12 European investigational sites. Completion of the study is expected this year, and results will support CE mark and pre-market approval submissions reports Vivasure Medical.
Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines

By using this website you agree to accept Medical Device News Magazine Privacy Policy